Ligand validation:3R9W

MRD: (4R)-2-METHYLPENTANE-2,4-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3R9W_MRD_A_507	34%	92%	0.199	0.884	0.3	0.24	-	-	2	0	100%	1
3R9W_MRD_A_508	13%	87%	0.253	0.799	0.3	0.38	-	-	4	0	100%	1
3R9X_MRD_A_503	35%	73%	0.224	0.914	0.28	0.74	-	-	4	0	100%	1
6B6R_MRD_A_307	100%	70%	0.037	0.984	0.6	0.57	-	-	0	0	100%	1
2BJK_MRD_A_1519	100%	71%	0.042	0.985	0.5	0.61	-	-	0	0	100%	1
5SZD_MRD_A_102	98%	93%	0.06	0.984	0.3	0.17	-	-	0	0	100%	1
4DUI_MRD_A_202	98%	59%	0.06	0.982	0.8	0.79	-	-	0	0	100%	1
1SWU_MRD_A_1	97%	67%	0.05	0.967	0.44	0.83	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.